-
-
-
-
-
-
-
BioCryst completes $700 million Astria acquisition
-
-
-
-
-
-
-
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) PT Raised to $15 at RBC Capital Amid 10pct Decline
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Appoints Vincent Milano to its Board
-
-
-
-
-
-
-
After-Hours Movers 01/27: (XLRN) (SURF) (INO) Higher; (EROS) (FFIV) (RMBS) Lower (more...)
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Appoints Theresa Heggie to Board
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Announces Termination of Merger Agreement with Idera Pharmaceuticals (IDRA)
-
1,158,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

